Riskpilot← Back to searchSign inGet full accessVårdkonsult i Härryda AB
ABActiveOrg 5567411409Idrottsgatan 27 Lgh 1201General medical practice activities · NACE 8621Est. 20071-4 employees
Revenue 2024
SEK 2M
+24% vs 2023
EBITDA margin
24.3%
+2% vs 2023
Equity ratio
40.1%
Financial strength
Net profit 2024
SEK 348K
-11% vs 2023
| Revenue | SEK 2M | +24% |
| EBITDA | SEK 476K | +2% |
| Net profit | SEK 348K | -11% |
| Total assets | SEK 3M | +0% |
| Equity | SEK 1,2M | +4% |
| Employees | — | — |
Legal name
Vårdkonsult i Härryda AB
Org number
5567411409
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
29 oktober 2007
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att vara praktiserande läkare som specialist i allmänmedicin, kognitiv terapeut, bedriva undervisning samt äga och förvalta fast och lös egendom och därmed förenlig verksamhet.
Address
Idrottsgatan 27 Lgh 1201
Email
leena.steen@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 836 | 1 780 | 1 664 | 1 579 | 1 958 |
| Staff expenses | — | — | — | −816 | — |
| EBITDA | 634 | 694 | 783 | 468 | 476 |
| Depreciation & amort. | −0 | −0 | −0 | — | −0 |
| EBIT | 634 | 694 | 783 | 468 | 476 |
| Net financials | −26 | −26 | −35 | −16 | −26 |
| Profit before tax | 589 | 638 | 907 | 503 | 454 |
| Tax | −130 | −135 | −195 | −111 | −106 |
| Net profit | 459 | 503 | 712 | 392 | 348 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 953 | 2 812 | 2 987 | 2 988 | 2 993 |
| Equity | 746 | 749 | 1 110 | 1 152 | 1 200 |
| Long-term debt | 734 | 694 | 654 | 614 | 574 |
| Short-term debt | 223 | 90 | 102 | 151 | 152 |
| Total debt | 957 | 784 | 756 | 765 | 726 |
EBITDA margin
24.3%
This company
15.8%
Market median
+54% vs market
20202024
Equity ratio
40.1%
This company
38.2%
Market median
+5% vs market
20202024
Return on equity
29.0%
This company
18.4%
Market median
+58% vs market
20202024
Net profit margin
17.8%
This company
8.1%
Market median
+120% vs market
20202024
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
20202024
Debt / equity
1.49×
This company
0.62×
Market median
-140% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
JH Chief Auditor | Chief Auditor | 2022 – 2025 |
ZM Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vårdkonsult i Härryda AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Henric Lyrebrant | Chief Auditor | 0 companies |
| Zlatan Mitrovic | Audit | 0 companies |
| Monica Kerstin Carita Leandersson | Deputy Board Member | 0 companies |
| Anna-Karin Pauline Steen | Deputy Board Member | 0 companies |
| Maria Leena Steen | Board of Directors | 0 companies |